Promethera Biosciences is based in Mont-Saint-Guibert, Belgium. It has raised $132M in total funding. Latest round: Series D.
Promethera Biosciences is based in Mont-Saint-Guibert, Belgium. Promethera Biosciences has raised $132M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2019. The round record for Promethera Biosciences runs through 2019; nothing later has been disclosed. Investors on record include Shinsei Capital Partners, Cyril Janssen, Marc Speeckaert, Olivier VAN DER Rest, Ci:z Investment, Korea Investment Partners and 5 others. 11 distinct backers are named across the disclosed rounds.
Totals shown for Promethera Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Mont-Saint-Guibert and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026